MUC1 and neoplasm: As aforementioned, DC-based vaccines can be sensitive to a mixture of antigens, thus applying the data from the single-cell RNA-sequencing technique, besides the well-known immunosuppressive-inducer antigens such as MUC1, can improve the efficacy of DC-based vaccines in the pro-inflammatory tumor microenvironment.